机器人辅助治疗不可切除的胰腺癌和远端胆管癌。
Robotic palliation for unresectable pancreatic cancer and distal cholangiocarcinoma.
机构信息
Division of General, Minimally Invasive and Robotic Surgery, Department of Surgery, University of Illinois at Chicago, 840 S. Wood Street, Chicago, IL 60612, USA.
出版信息
Int J Med Robot. 2011 Mar;7(1):60-5. doi: 10.1002/rcs.370. Epub 2010 Dec 29.
BACKGROUND
Optimizing quality of life is a major goal for patients with unresectable pancreatic cancer and distal cholangiocarcinoma. The aim of this study was to assess the value of robotic surgery for palliation in these patients.
METHODS
Between May 2007 and January 2010, nine patients who presented with unresectable pancreatic cancer or distal cholangiocarcinoma at exploratory laparoscopy were included in this retrospective study.
RESULTS
Eight hepaticojejunostomies, one choledochoduodenostomy and five gastrojejunostomies were performed robotically. Mean operative time was 236 ± 25 min. Median length of stay was 6 (range 4-10) days. There was no perioperative mortality. The morbidity rate was 22.2%. After a median follow-up of 265 days, there were no other readmissions for problems related to the operation.
CONCLUSIONS
Robotic palliation in cases of unresectable pancreatic cancer or distal cholangiocarcinoma is feasible and effective. The use of robotics in palliative surgery offers low morbidity, short hospital stay and minimal readmissions.
背景
提高生活质量是不可切除的胰腺癌和远端胆管癌患者的主要目标。本研究旨在评估机器人手术在这些患者姑息治疗中的价值。
方法
2007 年 5 月至 2010 年 1 月，对 9 例经剖腹探查术诊断为不可切除的胰腺癌或远端胆管癌的患者进行了回顾性研究。
结果
共完成 8 例肝肠吻合术、1 例胆总管十二指肠吻合术和 5 例胃空肠吻合术。平均手术时间为 236±25 分钟。中位住院时间为 6（4-10）天。无围手术期死亡。发病率为 22.2%。中位随访 265 天后，无其他与手术相关的再入院。
结论
机器人技术在不可切除的胰腺癌或远端胆管癌的姑息治疗中是可行和有效的。在姑息性手术中使用机器人技术具有较低的发病率、较短的住院时间和最小的再入院率。
Zotero 插件